We produced novel anti‐HER3 mAb that exerted anti‐tumor effects on human colon and breast cancer cells in xenografted mouse models,18 and recently developed specific anti‐MET mAb28, 29 in addition to transporters20, 25, 26, 28, 29 and adhesion molecules.17, 21, 28, 29. This evidence concerns the gene MET and breast carcinoma.